Everett Harris & Co
- SEC CIK
- 0001009254
- Latest filing
- Aug 3, 2026
FMS holding history
Fresenius Medical Care AG in every 13F filed by Everett Harris & Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
FMS overviewAll 13F holders of FMSFull Q2 2026 holdings
- Shares (Q1 2026)
- 0
- Sold out in Q1 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 20
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2026 | 0 | $0 | 0.0% | −12,839−100.0% | Sold out | Holders |
| Q4 2025 | 12,839 | $305.8K | <0.1% | −420−3.2% | Reduced | Holders |
| Q3 2025 | 13,259 | $349.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 13,259 | $378.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 13,259 | $330.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 13,259 | $300.2K | <0.1% | −340−2.5% | Reduced | Holders |
| Q3 2024 | 13,599 | $289.7K | <0.1% | −2,694−16.5% | Reduced | Holders |
| Q2 2024 | 16,293 | $311.0K | <0.1% | −4,364−21.1% | Reduced | Holders |
| Q1 2024 | 20,657 | $398.3K | <0.1% | −933−4.3% | Reduced | Holders |
| Q4 2023 | 21,590 | $449.7K | <0.1% | −208−1.0% | Reduced | Holders |
| Q3 2023 | 21,798 | $469.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 21,798 | $521.6K | <0.1% | −792−3.5% | Reduced | Holders |
| Q1 2023 | 22,590 | $480.3K | <0.1% | −9,460−29.5% | Reduced | Holders |
| Q4 2022 | 32,050 | $524.0K | <0.1% | −3,826−10.7% | Reduced | Holders |
| Q3 2022 | 35,876 | $504.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 35,876 | $895.0K | <0.1% | −400−1.1% | Reduced | Holders |
| Q1 2022 | 36,276 | $1.22M | <0.1% | −1,173−3.1% | Reduced | Holders |
| Q4 2021 | 37,449 | $1.22M | <0.1% | −3,676−8.9% | Reduced | Holders |
| Q3 2021 | 41,125 | $1.44M | <0.1% | −1,580−3.7% | Reduced | Holders |
| Q2 2021 | 42,705 | $1.77M | <0.1% | −8,915−17.3% | Reduced | Holders |
| Q1 2021 | 51,620 | $1.90M | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.